This is further supported by the fact that KRAS G12V degradation causes an increase in the number of macrophages with the M2 phenotype, which is active in tumor promotion, and a specific number of macrophages with the M1 phenotype, which is antitumor [81]. The gene discussed is KRAS; the disease is neoplasm.